Dextera Surgical to Announce Fiscal 2018 First Quarter Financial Results on Thursday November 9, 2017
October 30 2017 - 8:30AM
Business Wire
Dextera Surgical Inc. (Nasdaq: DXTR), a company commercializing
and developing the MicroCutter 5/80™ Stapler, today announced that
it will release financial results for its fiscal 2018 first quarter
ended September 30, 2017, on Thursday, November 9, 2017, after the
markets close. Dextera Surgical’s management will hold a conference
call at 4:30 p.m. Eastern Time to discuss the financial results and
provide an update on the company’s business.
Conference Call Details
To access the live conference call on November 9, 2017, at 4:30
p.m. Eastern Time via phone, please dial 844-419-1785 from the
United States and Canada or 216-562-0472. The conference ID is
1696019. Please dial in approximately 10 minutes prior to the start
of the call. A telephone replay will be available beginning
approximately four hours after the call through November 16, 2017,
and may be accessed by dialing 855-859-2056 from the United States
and Canada or 404-537-3406 internationally. The replay passcode is
1696019.
To access the live and subsequently archived webcast of the
conference call, go to the Investor Relations section of the
company’s website at ir.dexterasurgical.com. Please connect to the
website at least 15 minutes prior to the presentation to allow for
any necessary software downloads.
The webcast is also being distributed through the Thomson
StreetEvents Network. Institutional investors can access the call
via Thomson StreetEvents at www.streetevents.com, a
password-protected event management site.
About Dextera Surgical
Dextera Surgical designs and manufactures proprietary
stapling devices for minimally invasive surgical procedures. In the
U.S., surgical staplers are routinely used in more than one million
minimally invasive laparoscopic, video-assisted or robotic-assisted
surgical procedures annually.
Dextera Surgical also markets the only automated
anastomosis devices for coronary artery bypass graft (CABG) surgery
on the market today: the C-Port® Distal Anastomosis Systems and
PAS-Port® Proximal Anastomosis System. These products, sold
by Dextera Surgical under the Cardica brand name, have
demonstrated long-term reliable clinical performance for more than
a decade.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171030005388/en/
Dextera Surgical Inc.Bob Newell, 650-331-7133Vice President,
Finance and Chief Financial
Officerinvestors@dexterasurgical.com